Welcome to our dedicated page for Trilogy Metals SEC filings (Ticker: TMQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Trilogy Metals Inc. (TMQ) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, including Form 8-K current reports, shelf registration statements and related prospectus supplements. As a metal exploration and development company listed on NYSE American, Trilogy uses these filings to report material events tied to its Upper Kobuk Mineral Projects (UKMP) in Alaska, capital-raising programs, strategic transactions and financial results.
Form 8-K filings for Trilogy Metals cover topics such as entry into equity distribution agreements for at-the-market (ATM) offerings, the establishment and replacement of shelf registration statements on Form S-3, and the completion or termination of prior ATM programs. These documents detail the aggregate amounts of common shares that may be sold, the agents involved, commission structures and the legal framework governing the offerings. Other 8-Ks furnish press releases reporting quarterly financial results, providing investors with an official record of net losses, operating expenditures and cash positions as described by the company.
Trilogy also files 8-Ks to disclose project-related and strategic developments. Examples include updates on the Ambler Access Project, where the company reports on federal right-of-way permits and presidential decisions under the Alaska National Interest Lands Conservation Act, and a binding letter of intent with the U.S. Department of War for a strategic investment intended to advance exploration and development of the UKMP. These filings outline key terms such as planned investments, warrant and option structures, board appointment rights and covenants on future indebtedness.
On Stock Titan, users can review these SEC filings as they are pulled from EDGAR in near real time and supported by AI-generated explanations that summarize the main points of lengthy legal documents. This includes highlighting the significance of new ATM programs, strategic investments, project permits and other disclosures that may affect Trilogy Metals’ exploration and development activities in the Ambler Mining District.
Trilogy Metals Inc. reported a director stock option grant for William Beckwith Hayden. On 12/11/2025, he was awarded options to buy 50,000 common shares of Trilogy Metals.
The options have an exercise price of $4.61 per share, which was converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00. The options become exercisable on 12/11/2025 and expire on 12/10/2030. After this grant, he beneficially owns 50,000 derivative securities directly.
Trilogy Metals Inc. (TMQ) reported an insider equity award for director James Gowans. On 12/11/2025, he received a director stock option covering 50,000 common shares at an exercise price of $4.61 per share. The option is exercisable starting 12/11/2025 and expires on 12/10/2030.
The exercise price was converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00, so the award is valued and reported in U.S. dollars for disclosure purposes.
Trilogy Metals Inc. (TMQ)
Following this transaction, Sanders directly beneficially owns 3,332,895 common shares of Trilogy Metals. The RSUs originated from a grant on December 7, 2023 that vests in three equal installments on December 7, 2023, December 7, 2024, and December 7, 2025, aligning her compensation with long‑term shareholder value.
Trilogy Metals Inc. reported an insider equity transaction by its President and CEO, Tony Giardini. On December 7, 2025, he acquired 366,668 common shares of Trilogy Metals through the settlement of previously granted restricted stock units (RSUs), coded as an “M” transaction. After this transaction, he directly beneficially owned 8,698,728 common shares.
The RSUs originated from a grant made on December 7, 2023 that vested in three equal installments: one-third on December 7, 2023, one-third on December 7, 2024, and one-third on December 7, 2025. Following the conversion of 366,668 RSUs into common shares at an exercise price of $0, the reported RSU balance in the derivative securities table is 0, reflecting full settlement of this particular grant.
Trilogy Metals Inc. director reports option exercise, share sales, and gift of shares. On 12/05/2025, a director exercised an employee stock option for 50,000 common shares at a U.S. dollar exercise price of $1.82, converted from C$2.52 using an exchange rate of C$1.3860 = US$1.00.
The director then sold 20,000 common shares at $4.73 and a further 50,000 common shares at a weighted average price of $4.77, based on Canadian dollar prices between C$6.55 and C$6.701 converted at the same exchange rate. In addition, the director made a gift of 45,000 common shares at a price of $0.
Following these transactions, the director held 35,000 common shares directly and 252,000 common shares indirectly through a family trust, and held no remaining employee stock options from this grant.
Trilogy Metals Inc. director reports new deferred share units grant
A director of Trilogy Metals Inc. (TMQ) filed a Form 4 reporting a grant of 3,428.772 Deferred Share Units (DSUs) on 12/01/2025 at a price of $0 per unit. After this transaction, the director beneficially owns 555,079.536 derivative securities in the form of DSUs, held directly.
The DSUs were issued on a non-discretionary basis under elections made by plan participants before the start of the current fiscal year. The DSUs vest immediately, but the underlying common shares will not be issued, and the holder will not have voting or dispositive rights in those shares, until the director’s service with the company ends. The grants will expire no later than 90 days after the director’s termination date.
Trilogy Metals Inc. reported a routine insider equity transaction for a director on a Form 4. On 12/01/2025, the director received 3,551.228 Deferred Share Units (DSUs) at an exercise price of
The DSUs were issued on a non-discretionary basis under elections made before the start of the current fiscal year. The DSUs vest immediately, but the underlying common shares will only be issued after the director’s service with Trilogy Metals ends, and no voting or sale rights apply to those shares until that time. The grants will expire no later than 90 days after the director’s termination date.
Trilogy Metals Inc.12/01/2025, he received 3,122.632 Deferred Share Units (DSUs) under a non-discretionary plan, at an exercise price of
The DSUs vest immediately, but the underlying common shares are not issued, and he has no voting or dispositive rights over those shares, until his service as a director ends. The DSU grants will expire no later than 90 days after his termination date. This filing reflects routine director compensation in equity form rather than a market purchase or sale of Trilogy Metals shares.
Trilogy Metals Inc. director reports new deferred share units grant
A director of Trilogy Metals Inc. (TMQ) reported a new equity award effective 12/01/2025. The filing shows an acquisition of 3,122.632 Deferred Share Units (DSUs) at a price of $0, described as a non-discretionary issuance made under elections submitted before the current fiscal year. Following this grant, the director beneficially owns 517,469.243 derivative securities in the form of DSUs on a direct basis.
The DSUs vest immediately, but the underlying common shares will only be issued after the director’s service with Trilogy Metals ends. Until that termination event, the director does not have voting or dispositive rights over the underlying common shares, and the grants will expire no later than 90 days after the termination date.
Trilogy Metals Inc. reported a director equity award using deferred share units (DSUs). On 12/01/2025, director William Beckwith Hayden received 2,816.491 DSUs at an exercise price of $0 per unit. Each DSU represents the right to receive one common share, so the award is tied to 2,816.491 common shares.
After this grant, Hayden beneficially owned 483,208.857 derivative securities in total. The DSUs vest immediately, but the related common shares will only be issued after Hayden’s service as a director ends. Until then, he will not have voting or dispositive rights over the underlying shares, and the grants will expire no later than 90 days after his termination date.
FAQ
What is the current stock price of Trilogy Metals (TMQ)?
What is the market cap of Trilogy Metals (TMQ)?
